Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
13/09/2007 19:36
PR Newswire
OOSTERHOUT, Netherlands, September 13 /PRNewswire/ --
- Two-Day Multiplexing Technology Symposium Brings Together Thought
Leaders in Life Sciences and Clinical Diagnostics to Share Ideas and
Best Practices
Luminex Corporation (Nasdaq: LMNX), the world leader in multiplexed
solutions, today announced the agenda for Planet xMAP Europe 2007, the
company's annual European end-user technology symposium. The two-day event
will be held 2-3 October at the Berlage's Exchange in Amsterdam, the
Netherlands, and will feature a range of presentations regarding Luminex's
flexible xMAP(R) multiplexing technology in clinical diagnostics and life
science research applications.
"We are thrilled to welcome xMAP technology end-users back to The
Netherlands for our fifth annual Planet xMAP Europe," said Paul C. Ladestein,
Director of European Operations for Luminex. "This event will allow
scientists, researchers and clinicians to come together to share best
practices and ideas not only about xMAP technology, but about the broader
role that multiplexing technology is playing to improve research and enhance
the quality of patient care."
Planet xMAP Europe 2007 will feature two days of presentations and
workshops. Day One, Tuesday, 2 October, will concentrate on xMAP-based
clinical diagnostics applications and include the following presentations:
-- Dr. John C. Carrano, Vice President, Research and Development Luminex
Corporation (USA) - "xMAPing the Future: A Vision of Innovative
Products and Dominant Solutions"
-- Dr. Susan J. Wong, Diagnostic Immunology Laboratory, Wadsworth Center
NYSDOH (USA) - "Comparison of AtheNA Multi-Lyte Bb Microsphere
Immunoassay to Two-Tier Serology for Laboratory Confirmation of Lyme Disease"
-- Dr. Mario J. Marcon, Director of Clinical/Molecular Microbiology,
Virology, & Immunoserology, Department of Laboratory Medicine Children's
Hospital, Columbus, OH (USA) - "Evaluation of the Plexus Epstein Barr Virus
Panels in a children's Hospital Setting"
-- Professor Kai Zacharowski, M.D., Ph.D., Chair of Cardiovascular
Anesthesia & Critical Care, Bristol Royal Infirmary (United Kingdom) -
"Cytokines - From Head to Toe"
-- Dr. Diana Pauly, Center for Biological Safety, Microbial Toxins,
Robert Koch-Institute (Germany) - "Simultaneous Detection of Bacterial and
Plant Toxins Using a Multiplex Magnetic Bead Assay"
-- Dr. Gary T. Brice, United States Navy Medical Research Unit,
Department of Immunology (Indonesia) - "Etiology of Respiratory Viral
Pathogens in Suspect H5N1 Samples in Indonesia"
Day Two of Planet xMAP Europe 2007, Wednesday, 3 October, will focus on
xMAP-based life science research applications and feature the following
presentations:
-- Dr. Marion Lanteri, Postdoctoral Fellow, Immunology - "Cytokine
Signature of Early Viral Infections"
-- Professor Thomas Herget, Ph.D., Director PLS R?/New Technology
Evaluation, Merck KGaA (Germany) - "Safety Biomarkers: Holy Grail of
Toxicology"
-- Dr. Jochen Schwenk, KTH - Royal Institute of Technology, Alba Nova
University Center, Department of Proteomics (Sweden) - "Multiplexed
Approaches within Antibody Proteomics"
-- Dr. Corrado M. Cilio, Cellular Autoimmunity Unit, Department of
Clinical Sciences and Pediatrics, Malmo University Hospital (Sweden) -
"MicroRNA"
-- Dr. Oliver Poetz, NMI, Natural and Medical Science Institute at the
University of Tuebingen (Germany) - "Magnetic Beads Work Better at Night"
-- Dr. Ben van Ommen, TNO Quality Life (The Netherlands), Head of
Nutrigenomics and Nutritional Systems Biology Activities - "The Targeted
Plasma Proteome in Personalized Health and Nutrition"
For additional information on Planet xMAP Europe 2007 or to register,
please visit http://www.planetxmap.com or contact Jenny Busch (+31-162-408333
(332) or xmapeurope@luminexcorp.com).
About Luminex
Luminex Corporation develops, manufactures and markets proprietary
biological testing technologies with applications throughout the diagnostic
and life sciences industries. The Company's xMAP(R) multiplex solutions
include an open-architecture, multi-analyte technology platform that delivers
fast, accurate and cost-effective bioassay results to markets as diverse as
pharmaceutical drug discovery, clinical diagnostics and biomedical research,
including the genomics and proteomics markets. The Company's xMAP technology
is sold worldwide and is already in use in leading clinical laboratories as
well as major pharmaceutical, diagnostic and biotechnology companies. Further
information on Luminex Corporation or xMAP can be obtained at
www.luminexcorp.com.
Luminex Corporate Contact:
Harriss T. Currie
Vice President, Finance and Chief Financial Officer
+1-512-219-8020
Luminex Media Contact:
Nicole Cottrill
+1-327-327-7999
Web site: http://www.luminexcorp.com
http://www.planetxmap.com
Harriss T. Currie, Vice President, Finance and Chief Financial Officer, +1-512-219-8020, or Media, Nicole Cottrill, +1-327-327-7999